Cancer is the second leading cause of death worldwide, requiring more effective treatments. By-products from the white shrimp (Penaeus vannamei) are a promising source of bioactive compounds. Compounds with antiproliferative activity were isolated and identified in exoskeleton and cephalothorax extracts. The hexane extract of the exoskeleton reduced the viability of Human Prostate Carcinoma cell line (22Rv1) to 40.6% without toxicity in Adult Retinal Pigment Epithelium-19 (ARPE-19). Among the 19 fractions obtained, H3 reduced cell viability to 20.78%. Spectroscopic analysis identified bis(2-ethylhexyl) terephthalate, neoxanthin, and violaxanthin. Fluorescence microscopy showed morphological alterations. These findings demonstrate in vitro antiproliferative activity of compounds derived from shrimp by-products and support further studies to elucidate their mechanisms of action and evaluate their potential relevance in cancer prevention or therapeutic research.
Trujillo-Ruiz et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: